Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors

Although early treatment of Crohn’s disease (CD) patients with anti-tumor necrosis factor (TNF) agents or immunomodulators (IMs) may improve long-term outcomes, especially those with poor prognostic factors, their effectiveness in Asians remains unclear. In this study, Korean patients with CD naïve...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Eun Hye, Oh, Kyunghwan, Han, Minkyu, Seo, Hyungil, Chang, Kiju, Lee, Sun-Ho, Kim, Gwang-Un, Song, Eun Mi, Seo, Myeongsook, Lee, Ho-Su, Hwang, Sung Wook, Park, Sang Hyoung, Yang, Dong-Hoon, Kim, Kyung-Jo, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun, Ye, Byong Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441601/
https://www.ncbi.nlm.nih.gov/pubmed/28542298
http://dx.doi.org/10.1371/journal.pone.0177479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441601/
https://www.ncbi.nlm.nih.gov/pubmed/28542298
http://dx.doi.org/10.1371/journal.pone.0177479

Ejemplares similares